Richard J. Whitley, MD
Distinguished Professor, Loeb Scholar Chair in Pediatrics, Professor of Pediatrics, Microbiology, Medicine, and Neurosurgery, University of Alabama at Birmingham

Dr. Whitley joined Gilead's Board of Directors in 2008. He is a Distinguished Professor, Loeb Scholar Chair in Pediatrics, and Professor of Microbiology, Medicine and Neurosurgery at the University of Alabama at Birmingham. He is the Co-Director, Division of Pediatric Infectious Diseases; Vice-Chair, Department of Pediatrics; Senior Scientist, Department of Gene Therapy; Director for Drug Discovery and Development and Senior Leader, Comprehensive Cancer Center; Associate Director for Clinical Studies, Center for AIDS Research; and Co-Founder and Co-Director, Alabama Drug Discovery Alliance. Dr. Whitley is responsible for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group, and directs a Center for drug discovery in the arena of emerging infections. He is a past President of the International Society of Antiviral Research and the Infectious Diseases Society of America, and currently chairs both the NIAID Recombinant DNA Advisory Council and the NIAID HIV Vaccine Data Safety and Management Board. He is an elected member of the American Society of Clinical Investigation and the Association of American Physicians. He is an Honorary Member of the Irish Academy of Science.

NASDAQ (US Dollar)
$67.63
 Stock is Down 0.39 (0.57%)
Data as of 05/21/18 1:58 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
2018 Annual Meeting of Stockholders

May 09, 2018 10:00 a.m. PT
Play
First Quarter 2018 Gilead Sciences Earnings Conference Call

May 01, 2018 1:30 p.m. PT
Play
Gilead Sciences at the RBC Capital Markets 2018 Global Healthcare Conference

February 21, 2018 9:00 a.m. ET
Play
36th Annual J.P. Morgan Healthcare Conference

January 08, 2018 3:30 p.m. PT
Play